CANCERNA Partners held a face-to-face meeting on September 5-6, 2022 meeting in Jerusalem
Breakthrough RNA-Based Anti-Cancer Immunotherapy Treatments Being Developed by Global Consortium led by the Hadassah Cancer Research Institute
HADASSAH AND DRUG GIANT MERCK LAUNCH MRNA INITIATIVE TO FIGHT CANCER
Immunyx Pharma Part of Global Consortium CanceRNA Developing RNA-based Cancer Vaccine